<p>根据澳大利亚超级公司（AustralianSuper Pty Ltd）最近向美国证券交易委员会（SEC）披露的信息，该公司在第三季度将其在沃特世（Waters Co.，NYSE:WAT - 免费报告）的持股比例降低了 40.4%。在该季度出售了 5,683 股后，机构投资者目前持有 8,378 股该医疗仪器供应商的股票。截至其最近向 SEC 提交的文件，澳大利亚超级公司在沃特世的持股价值为 3,015,000 美元。</p>
<ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
<p>其他几家对冲基金和机构投资者最近也买卖了该股票的股份。SG 美洲证券公司（SG Americas Securities LLC）在第一季度将其在沃特世的持股提高了 55.1%。SG 美洲证券公司目前持有 14,765 股该医疗仪器供应商的股票，价值 5,083,000 美元，此前在上个季度又购买了 5,248 股。TD 资产管理公司（TD Asset Management Inc）在第一季度将其在沃特世的持股提高了 4.3%。TD 资产管理公司目前持有 443,493 股该医疗仪器供应商的股票，价值 152,664,000 美元，此前在上个季度又购买了 18,274 股。梅迪奥兰国际基金有限公司（Mediolanum International Funds Ltd）在第一季度购买了沃特世的新头寸，价值约为 1,786,000 美元。瑞典银行（Swedbank AB）在第一季度获得了沃特世的新股份，价值约为 10,106,000 美元。最后，贝斯默集团（Bessemer Group Inc.）在第一季度将其在沃特世的持股增加了 67.5%。贝斯默集团目前持有 10,382 股该医疗仪器供应商的股票，价值 3,574,000 美元，此前在上个季度又购买了 4,184 股。94.01% 的股票由机构投资者和对冲基金持有。</p>
<h2>沃特世股票下跌 1.2%</h2>
<p>周五，沃特世股票开盘价为 322.57 美元。沃特世的 1 年最低价为 234.04 美元，1 年最高价为 367.21 美元。该公司的市值为 191.5 亿美元，市盈率为 32.13，市盈增长比率为 6.42，贝塔值为 0.95。该公司的 50 日移动平均价格为 341.42 美元，200 日移动平均价格为 324.75 美元。该公司的债务与股本比率为 1.42，流动比率为 2.10，速动比率为 1.42。</p>
<ul>
<li>医疗股票沃特世、安捷伦、艾克曼显示增长潜力</li>
</ul>
<p>沃特世（NYSE:WAT - 获取免费报告）最近在 7 月 31 日（星期三）发布了季度财报。该医疗仪器供应商报告本季度每股收益为 2.63 美元，超出市场共识预期的 2.55 美元，超出 0.08 美元。该公司本季度的收入为 7.09 亿美元，而市场共识预期为 7.00 亿美元。沃特世的净利润率为 20.71%，股本回报率为 56.81%。与去年同期相比，该公司的季度收入下降了 4.3%。在去年同期，该公司每股收益为 2.80 美元。整体来看，研究分析师预测沃特世将在当前年度发布 11.6 美元的每股收益。</p>
<h2>华尔街分析师观点</h2>
<p>沃特世最近成为多份分析师报告的主题。德意志银行（Deutsche Bank Aktiengesellschaft）在 8 月 1 日（星期四）的研究报告中将沃特世的目标股价从 330.00 美元下调至 310.00 美元，并对该公司给予 “持有” 评级。富国银行（Wells Fargo &amp; Company）在 8 月 27 日（星期二）的研究报告中开始覆盖沃特世的股票。他们给予该公司 “增持” 评级，并设定目标股价为 380.00 美元。TD Cowen 在 8 月 1 日（星期四）的研究报告中将沃特世的目标股价从 325.00 美元提高至 363.00 美元，并给予该股票 “持有” 评级。Leerink Partners 在 8 月 1 日（星期四）的研究报告中将沃特世的评级从 “持有” 上调至 “强力买入”。最后，巴克莱（Barclays）在 10 月 15 日（星期二）的研究报告中将沃特世的目标股价从 300.00 美元上调至 330.00 美元，并给予该公司 “减持” 评级。一位分析师对该股票给予了卖出评级，九位分析师给予了持有评级，三位分析师给予了买入评级，一位分析师给予了强力买入评级。根据 MarketBeat.com 的数据，沃特世目前的平均评级为 “持有”，共识目标价为 342.58 美元。</p>
<p><strong>阅读我们最新的沃特世股票分析</strong></p>
<h2>沃特世公司简介</h2>
<p>（免费报告）</p>
<p>沃特世公司在亚洲、美洲和欧洲提供分析工作流程解决方案。它通过两个部门运营：沃特世和 TA。该公司设计、制造、销售和服务高效和超高效液相色谱以及质谱（MS）技术系统和支持产品，包括色谱柱、其他消耗品和保修后服务计划。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比沃特世更好</li>
<li>如何使用 MarketBeat Excel 股息计算器</li>
<li>微软今年能创下新高 - 这是为什么</li>
<li>投资者需要了解即将上市的 IPO</li>
<li>Zillow 股票的牛市案例：为什么这次近期抛售可能是一个买入机会</li>
<li>为什么特别股息对收入投资者来说可能是一个令人愉快的惊喜</li>
<li>IonQ 的量子激增：是乘风破浪还是套现？</li>
</ul>
<p><strong>想看看其他对冲基金持有的 WAT 吗？</strong> 访问 HoldingsChannel.com 以获取沃特世公司（NYSE:WAT - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审查。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<p>→ 我错了。完全错了。（来自 Porter &amp; Company）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDIyMg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDIyMg"/></p>
<h2>你现在应该投资 1,000 美元在沃特世吗？</h2>
<p>在考虑沃特世之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而沃特世并不在名单上。</p>
<p>虽然沃特世目前在分析师中被评为 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

沃特世

<p>澳大利亚超级养老金公司（AustralianSuper Pty Ltd）在第三季度将其在沃特世（Waters Co.，NYSE:WAT）的持股比例减少了 40.4%，目前持有 8,378 股，价值 1,015,000 美元。其他机构投资者也调整了他们的持仓，SG Americas 将其持股增加了 55.1%。沃特世的股票开盘价为 75.57 美元，下跌 1.2%，市值为 151.5 亿美元。该公司报告第二季度每股收益为 1.63 美元，超出预期，但收入同比下降了 4.3%。分析师对该股票的评级不一，平均评级为 “持有”，共识目标价为 78.58 美元</p>

<p>AustralianSuper Pty Ltd lowered its stake in Waters Co. (NYSE:WAT - Free Report) by 40.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 8,378 shares of the medical instruments supplier's stock after selling 5,683 shares during the quarter. AustralianSuper Pty Ltd's holdings in Waters were worth $3,015,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>根据澳大利亚超级公司（AustralianSuper Pty Ltd）最近向美国证券交易委员会（SEC）披露的信息，该公司在第三季度将其在沃特世（Waters Co.，NYSE:WAT - 免费报告）的持股比例降低了 40.4%。在该季度出售了 5,683 股后，机构投资者目前持有 8,378 股该医疗仪器供应商的股票。截至其最近向 SEC 提交的文件，澳大利亚超级公司在沃特世的持股价值为 3,015,000 美元。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技因 “永恒化学品” 打击而蓬勃发展</li>
</ul>
</div><p>Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. SG Americas Securities LLC lifted its holdings in Waters by 55.1% in the 1st quarter. SG Americas Securities LLC now owns 14,765 shares of the medical instruments supplier's stock worth $5,083,000 after buying an additional 5,248 shares in the last quarter. TD Asset Management Inc boosted its holdings in Waters by 4.3% in the first quarter. TD Asset Management Inc now owns 443,493 shares of the medical instruments supplier's stock valued at $152,664,000 after purchasing an additional 18,274 shares during the last quarter. Mediolanum International Funds Ltd purchased a new position in Waters in the first quarter valued at about $1,786,000. Swedbank AB acquired a new stake in Waters during the 1st quarter valued at approximately $10,106,000. Finally, Bessemer Group Inc. increased its holdings in Waters by 67.5% during the 1st quarter. Bessemer Group Inc. now owns 10,382 shares of the medical instruments supplier's stock worth $3,574,000 after purchasing an additional 4,184 shares during the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者最近也买卖了该股票的股份。SG 美洲证券公司（SG Americas Securities LLC）在第一季度将其在沃特世的持股提高了 55.1%。SG 美洲证券公司目前持有 14,765 股该医疗仪器供应商的股票，价值 5,083,000 美元，此前在上个季度又购买了 5,248 股。TD 资产管理公司（TD Asset Management Inc）在第一季度将其在沃特世的持股提高了 4.3%。TD 资产管理公司目前持有 443,493 股该医疗仪器供应商的股票，价值 152,664,000 美元，此前在上个季度又购买了 18,274 股。梅迪奥兰国际基金有限公司（Mediolanum International Funds Ltd）在第一季度购买了沃特世的新头寸，价值约为 1,786,000 美元。瑞典银行（Swedbank AB）在第一季度获得了沃特世的新股份，价值约为 10,106,000 美元。最后，贝斯默集团（Bessemer Group Inc.）在第一季度将其在沃特世的持股增加了 67.5%。贝斯默集团目前持有 10,382 股该医疗仪器供应商的股票，价值 3,574,000 美元，此前在上个季度又购买了 4,184 股。94.01% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Waters Stock Down 1.2 %</h2>
<div class="lb-trans"><h2>沃特世股票下跌 1.2%</h2>
</div><p>Shares of Waters stock opened at $322.57 on Friday. Waters Co. has a 1-year low of $234.04 and a 1-year high of $367.21. The company has a market capitalization of $19.15 billion, a P/E ratio of 32.13, a PEG ratio of 6.42 and a beta of 0.95. The business's fifty day moving average price is $341.42 and its two-hundred day moving average price is $324.75. The company has a debt-to-equity ratio of 1.42, a current ratio of 2.10 and a quick ratio of 1.42.</p>
<div class="lb-trans"><p>周五，沃特世股票开盘价为 322.57 美元。沃特世的 1 年最低价为 234.04 美元，1 年最高价为 367.21 美元。该公司的市值为 191.5 亿美元，市盈率为 32.13，市盈增长比率为 6.42，贝塔值为 0.95。该公司的 50 日移动平均价格为 341.42 美元，200 日移动平均价格为 324.75 美元。该公司的债务与股本比率为 1.42，流动比率为 2.10，速动比率为 1.42。</p>
</div><ul>
<li>Medical Stocks Waters, Agilent, Illumina Show Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗股票沃特世、安捷伦、艾克曼显示增长潜力</li>
</ul>
</div><p>Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $2.63 earnings per share for the quarter, topping the consensus estimate of $2.55 by $0.08. The business had revenue of $709.00 million during the quarter, compared to the consensus estimate of $700.09 million. Waters had a net margin of 20.71% and a return on equity of 56.81%. The company's quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.80 earnings per share. As a group, research analysts forecast that Waters Co. will post 11.6 EPS for the current year.</p>
<div class="lb-trans"><p>沃特世（NYSE:WAT - 获取免费报告）最近在 7 月 31 日（星期三）发布了季度财报。该医疗仪器供应商报告本季度每股收益为 2.63 美元，超出市场共识预期的 2.55 美元，超出 0.08 美元。该公司本季度的收入为 7.09 亿美元，而市场共识预期为 7.00 亿美元。沃特世的净利润率为 20.71%，股本回报率为 56.81%。与去年同期相比，该公司的季度收入下降了 4.3%。在去年同期，该公司每股收益为 2.80 美元。整体来看，研究分析师预测沃特世将在当前年度发布 11.6 美元的每股收益。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>WAT has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Waters from $330.00 to $310.00 and set a &#34;hold&#34; rating for the company in a research report on Thursday, August 1st. Wells Fargo &amp; Company started coverage on shares of Waters in a research report on Tuesday, August 27th. They issued an &#34;overweight&#34; rating and a $380.00 target price for the company. TD Cowen increased their price target on shares of Waters from $325.00 to $363.00 and gave the stock a &#34;hold&#34; rating in a research report on Thursday, August 1st. Leerink Partnrs upgraded Waters from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Thursday, August 1st. Finally, Barclays upped their price objective on Waters from $300.00 to $330.00 and gave the company an &#34;underweight&#34; rating in a research note on Tuesday, October 15th. One analyst has rated the stock with a sell rating, nine have issued a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Waters presently has an average rating of &#34;Hold&#34; and a consensus target price of $342.58.</p>
<div class="lb-trans"><p>沃特世最近成为多份分析师报告的主题。德意志银行（Deutsche Bank Aktiengesellschaft）在 8 月 1 日（星期四）的研究报告中将沃特世的目标股价从 330.00 美元下调至 310.00 美元，并对该公司给予 “持有” 评级。富国银行（Wells Fargo &amp; Company）在 8 月 27 日（星期二）的研究报告中开始覆盖沃特世的股票。他们给予该公司 “增持” 评级，并设定目标股价为 380.00 美元。TD Cowen 在 8 月 1 日（星期四）的研究报告中将沃特世的目标股价从 325.00 美元提高至 363.00 美元，并给予该股票 “持有” 评级。Leerink Partners 在 8 月 1 日（星期四）的研究报告中将沃特世的评级从 “持有” 上调至 “强力买入”。最后，巴克莱（Barclays）在 10 月 15 日（星期二）的研究报告中将沃特世的目标股价从 300.00 美元上调至 330.00 美元，并给予该公司 “减持” 评级。一位分析师对该股票给予了卖出评级，九位分析师给予了持有评级，三位分析师给予了买入评级，一位分析师给予了强力买入评级。根据 MarketBeat.com 的数据，沃特世目前的平均评级为 “持有”，共识目标价为 342.58 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on Waters</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的沃特世股票分析</strong></p>
</div><h2>Waters Profile</h2>
<div class="lb-trans"><h2>沃特世公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.</p>
<div class="lb-trans"><p>沃特世公司在亚洲、美洲和欧洲提供分析工作流程解决方案。它通过两个部门运营：沃特世和 TA。该公司设计、制造、销售和服务高效和超高效液相色谱以及质谱（MS）技术系统和支持产品，包括色谱柱、其他消耗品和保修后服务计划。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Waters</li>
<li>How to Use the MarketBeat Excel Dividend Calculator</li>
<li>Microsoft Can Hit New All-Time Highs This Year - Here’s Why</li>
<li>What Investors Need to Know About Upcoming IPOs</li>
<li>Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy</li>
<li>Why Special Dividends Can be a Delightful Surprise for Income Investors</li>
<li>IonQ’s Quantum Surge: Ride the Wave or Cash Out?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比沃特世更好</li>
<li>如何使用 MarketBeat Excel 股息计算器</li>
<li>微软今年能创下新高 - 这是为什么</li>
<li>投资者需要了解即将上市的 IPO</li>
<li>Zillow 股票的牛市案例：为什么这次近期抛售可能是一个买入机会</li>
<li>为什么特别股息对收入投资者来说可能是一个令人愉快的惊喜</li>
<li>IonQ 的量子激增：是乘风破浪还是套现？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding WAT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 WAT 吗？</strong> 访问 HoldingsChannel.com 以获取沃特世公司（NYSE:WAT - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdBVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=WAT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审查。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><p>→ I was wrong. Dead wrong. (From Porter &amp; Company)(Ad)</p>
<div class="lb-trans"><p>→ 我错了。完全错了。（来自 Porter &amp; Company）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xMDIyMg" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=10222&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Waters right now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在沃特世吗？</h2>
</div><p>Before you consider Waters, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑沃特世之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而沃特世并不在名单上。</p>
</div><p>While Waters currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然沃特世目前在分析师中被评为 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

澳大利亚超级有限公司出售了沃特世公司（NYSE:WAT）的股票